Telix Pharmaceuticals Limited (ASX:TLX)
Australia · Delayed Price · Currency is AUD 17.85
+0.40 (2.29%)
Sep 18, 2026, 4:10 PM AEST
Telix Pharmaceuticals Market Cap
Telix Pharmaceuticals has a market cap or net worth of 6.07 billion as of September 18, 2026. Its market cap has increased by 28.76% in one year.
Market Cap
6.07B
Enterprise Value
6.54B
Revenue
1.29B
Ranking
n/a
PE Ratio
129.46
Stock Price
17.85
ChartMarket Cap Chart
Since November 15, 2017, Telix Pharmaceuticals's market cap has increased from 152.03M to 6.07B, an increase of 3,889.52%. That is a compound annual growth rate of 51.69%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 18, 2026 | 6.07B | 59.88% |
| Dec 31, 2025 | 3.79B | -53.95% |
| Dec 31, 2024 | 8.24B | 152.44% |
| Dec 29, 2023 | 3.26B | 41.89% |
| Dec 30, 2022 | 2.30B | 4.10% |
| Dec 31, 2021 | 2.21B | 108.44% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Nov 15, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| CSL Limited | 84.09B |
| Mesoblast | 2.74B |
| PYC Therapeutics | 2.63B |
| Neuren Pharmaceuticals | 2.62B |
| Clarity Pharmaceuticals | 813.32M |
| Clinuvel Pharmaceuticals | 411.49M |
| Racura Oncology | 396.06M |
| Starpharma Holdings | 381.48M |